The U.S. FDA on Monday is expected to give its thumbs up or down on Biogen Inc's aducanumab, a decision that will affect the future of Alzheimer's disease research and treatment and show the agency's willingness to approve badly needed medicines based on less than definitive data.

The U.S. FDA on Monday is expected to give its thumbs up or down on Biogen Inc's aducanumab, a decision that will affect the future of Alzheimer's disease research and treatment and show the agency's willingness to approve badly needed medicines based on less than definitive data.

More than a year after COVID-19 temporarily shut down dental offices, then led to heightened sanitary demands upon reopening, dentists are urging people who got out of the habit of receiving regular dental care to come back to the hydraulic chair.

Opponents say the project would threaten roads, wildlife, and even the night sky itself, not to mention the lifeblood of the South Rim: water. Proponents point to economic development to serve an ever-increasing number of visitors.

Walking can be dangerous, depending where you live. In Michelle Mihalik’s case, Nevada is ranked eleventh in pedestrian fatalities, according to a report by Smart Growth America.

Humans may be able to live for between 120 and 150 years, but no longer than this "absolute limit" on human life span, a new study suggests.

For singletons, the urge to get back out there might be strong, but we’re still in a pandemic after all, and, while there’s light at the end of the tunnel, Covid’s impact on us and society at large is undeniable and unchangeable.

As society regains its pre-pandemic routine, many people are considering ending their relationships.

Worried about getting back out there?